Oriana is a visionary leader in the field of women’s health and diagnostics. Recently honored in Inc’s 2022 Top 100 Female Founders for her work in ovarian cancer diagnosis, Oriana brings a wealth of knowledge and expertise bringing disruptive diagnostics to market and changing the landscape of clinical practice. Oriana is passionate about entrepreneurship and problem solving and hopes to use these skills to revolutionize early cancer detection, particularly in cancers that disproportionately affect women.

Oriana has global experience creating and leading organizations resulting in successful strategic exits. Prior to AOA, she led teams at early-stage startups and large life sciences companies.

Oriana has a track record of developing a highly productive culture and turning visions into reality. She has a proven technical record of creating market entry strategies and product launches in new markets, including launching nationwide HPV screening in East Africa and novel diagnostics in maternal fetal medicine, oncology and infectious diseases.

As CEO of AOA, her dedication and work have earned her numerous awards and recognition, including the Massachusetts Life Sciences Centers MassNextGen Award, The Eddies People’s Choice Award and The Wave Summit’s Emerging Women Founder in Bio Award.

Oriana holds a degree from Boston University in Economics and International Relations, and she has experience both living and working in various geographies.